Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
L Sordo, G Barrio, MJ Bravo, BI Indave, L Degenhardt… - bmj, 2017 - bmj.com
Objective To compare the risk for all cause and overdose mortality in people with opioid
dependence during and after substitution treatment with methadone or buprenorphine and …
dependence during and after substitution treatment with methadone or buprenorphine and …
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a …
T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov… - The lancet, 2015 - thelancet.com
Background Up-to-date evidence about levels and trends in disease and injury incidence,
prevalence, and years lived with disability (YLDs) is an essential input into global, regional …
prevalence, and years lived with disability (YLDs) is an essential input into global, regional …
Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta …
Importance Mortality among people with opioid dependence is higher than that of the
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …
The burden of opioid-related mortality in the United States
Importance Opioid prescribing and overdose are leading public health problems in North
America, yet the precise public health burden has not been quantified. Objective To examine …
America, yet the precise public health burden has not been quantified. Objective To examine …
The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010
Background The Global Burden of Disease Study 2010 (GBD 2010), estimated that a
substantial proportion of the world's disease burden came from mental, neurological and …
substantial proportion of the world's disease burden came from mental, neurological and …
The increasing global health priority of substance use in young people
Substance use in young people (aged 10–24 years) might disrupt key periods of transition
that occur as the adolescent brain undergoes cognitive and emotional development, and …
that occur as the adolescent brain undergoes cognitive and emotional development, and …
A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth
BackgroundMental and substance use disorders are common and often persistent, with
many emerging in early life. Compared to adult mental and substance use disorders, the …
many emerging in early life. Compared to adult mental and substance use disorders, the …
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
BR Haight, SM Learned, CM Laffont, PJ Fudala, Y Zhao… - The Lancet, 2019 - thelancet.com
Background RBP-6000, referred to as BUP-XR (extended-release buprenorphine), is a
subcutaneously injected, monthly buprenorphine treatment for opioid use disorder. BUP-XR …
subcutaneously injected, monthly buprenorphine treatment for opioid use disorder. BUP-XR …
Modelling the combined impact of interventions in averting deaths during a synthetic‐opioid overdose epidemic
Background and aims The province of British Columbia (BC) Canada has experienced a
rapid increase in illicit drug overdoses and deaths during the last 4 years, with a provincial …
rapid increase in illicit drug overdoses and deaths during the last 4 years, with a provincial …
Extended‐release injectable naltrexone for opioid use disorder: a systematic review
Aims To review systematically the published literature on extended‐release naltrexone (XR‐
NTX, Vivitrol®), marketed as a once‐per‐month injection product to treat opioid use …
NTX, Vivitrol®), marketed as a once‐per‐month injection product to treat opioid use …